During the past decade, bitop AG conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "bitop AG" are "Acute Rhinosinusitis" (1 trials) and "Acute Viral Pharyngitis" (1 trials). Many other conditions were trialed in "bitop AG" in a lesser frequency.

Most popular intervention types in "bitop AG" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ectoin Lozenges Honey Lemon" (1 trials), "Ectoin Rhinosinusitis Nasal Spray" (1 trials), "Hyaluronic Acid/Icelandic moss Lozenges" (1 trials) and "Xylometazoline Nasal Spray" (1 trials). Other intervention names were less common.

The vast majority of trials in "bitop AG" are 2 trials for "All" genders.

Currently, there are NaN active trials in "bitop AG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in bitop AG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in bitop AG, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".